Transitioning to a new platform
2024-11-06
The journal is transitioning to a new platform under a new publisher " Wolters Kluwer / Medknow".
Submissions will be turned off on this platform starting 11/9/2024. The new website will be available in early December 2024. We will send an email to all users with the new link.
Appreciate all the support.
Editor-in-Chief
Awni Shahait, MD, FACS